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Adverse reactions to ﬁeld vaccination against
lumpy skin disease in cattle
S.M. Abutarbush
College of Food & Agriculture, Al Ain, United Arab
Emirates
Background: Lumpy skin disease (LSD) is an emerging pox dis-
ease that cancause serious losses in cattle industrydue todecreased
productivity, cost of veterinary treatments, death, and impact on
the international trade of live animals and animal products. The
disease originated from Africa, but it has spread to countries of the
Middle East and poses a serious threat to Europe andAsia. Recently,
ﬁeld veterinarians in Jordan reported a range of clinical signs seen
after the LSD vaccination in cattle.
Methods & Materials: During the outbreak of LSD in Jordan,
farmers outside the outbreak governorate (Irbid) were recom-
mended to vaccinate their cattle of all ages, types and sexes using a
sheep pox virus (SPPV) RM65 vaccine, Jovivac. After the vaccination
campaign was initiated, post vaccinal reactions were suspected.
Affected farms were investigated and data collected about animals
on each farm that practiced vaccination against LSD.
Results: Sixty-three dairy cattle farms, with a total of 19,539
animals, were included in the study. Of those, 56 farms reported
adverse clinical signs after vaccine administration. The duration
between vaccine administration and appearance of adverse clinical
signs ranged from 1 to 20 days (Mean = 10.3, SD 3.9). Clinical signs
were similar to those observed with natural cases of lumpy skin
disease.
These included fever and variable sized cutaneous nodules that
could be seen anywhere on the body. Some cattle had swollen
lymph nodes, while a few pregnant animals aborted. The percent-
age of affected cattle ranged from 0.3 to 25% (Mean = 8, SD 5.1).
Fever, decreased feed intake, and decreased milk production were
seen in 83.9, 85.7, and 94.6% in cattle on the affected farms, respec-
tively. All affected cattle displayed skin nodules over their entire
bodies. No mortalities were reported due to vaccine adverse reac-
tions. Duration (course) of clinical signs ranged from 3 to 20 days
(Mean = 13.7, SD 4.1).
Conclusion: LSD vaccines can be associated with severe reac-
tion that can be confusedwith natural infection. Further studies are
warranted to identify safe vaccines for this disease.
http://dx.doi.org/10.1016/j.ijid.2016.02.390
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Maximizing detection of dengue virus serotypes
by a modiﬁed reverse transcription-polymerase
chain reaction assay in India: presence of
co-infection with multiple serotypes
S.F. Ahamed1,∗, R. Vivek2, S. Kotabagi2, K.
Nayak3, A. Chandele3, M.K. Kaja3, A. Shet4
1 St. John’s Research Institute, Bangalore, Karnataka,
India
2 St. John’s Research Institute, Bangalore, India
3 International Centre for Genetic Engineering and
Biotechnology, New Delhi, India
4 St. John’s Medical College, Bangalore, India
Background: Dengue surveillance uses reverse transcription-
polymerase chain reaction (RT-PCR), although no standardized
method for Indian serotypes exists. We compared efﬁcacies of
known and modiﬁed primer sets targeting envelope (Env) and
capsid pre-membrane (C-prM) genes for detection of circulating
dengue virus (DENV) serotypes in southern India.
Methods & Materials: Acute samples from children with
clinically-diagnosed dengue were tested for NS1/anti-dengue-IgM.
Viral RNA was extracted and two-step nested RT-PCR was done
using 3 methods; in the ﬁrst, consensus primers targeted 654bp of
C-prM (CprM654) with a modiﬁed reverse primer; the second tar-
geted 511bp of C-prM (CprM511), and the third targeted 641bp of
Env (Env641). To ensure accuracy, sequencing (ABI, Applied Biosys-
tems) was done on all RT-PCR-positive samples; DENV sequences
were aligned using ClustalW, and compared with NCBI’s GenBank
database.
Results: Among 162 children (mean age 6.9yrs±4.3; males
61.0%) hospitalized between Nov 2014-Mar 2015, 113 were
‘dengue-positive’ (111 NS1-positive and 2 dengue-IgM-positive),
and49were ‘negative’ (undetectableNS1/dengue IgM/IgG). Among
113 positives, PCR detected 84 (74.3%) by CprM654, 66 (58.4%)
by CprM511, and 72 (63.7%) by Env641, suggesting high suitabil-
ity of CprM654 for regional DENV serotyping. Among 49 ‘negative’
samples, 10 (20.4%) were detected by CprM654, 11 (22.5%) by
CprM511, and 11 (22.5%) by Env641. Overall detection rate using
all three methods sequentially was 81.4% (92/113) among positive
and 38.7% (19/49) among negative samples. Consensus serotype
distribution (including multiple-serotype co-infection) was DENV-
1 (66, 59.4%), DENV-2 (28, 25.2%), DENV-3 (19, 17.1%) and DENV-4
(1, 0.9%). Co-infectionswithmultiple serotypeswere seen in 8 chil-
dren (4.9%); among these, increased severity and deathwas seen in
one child, and moderate severity in 4 children. Discordant results
were seen in6 (3.7%) samples, signifying either varying sensitivities
among RT-PCR methods, or presence of recombinant virus.
Conclusion: This is theﬁrst sequencing-conﬁrmedoptimization
study showing improved detection of circulating DENV serotypes
from symptomatic Indian children, using a modiﬁed RT-PCR
method and a testing algorithm. Our results showed a signiﬁcant
rate of co-infection with multiple serotypes. This method may be
usedwith immediate effect for national dengue surveillance,which
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is critical in hyper-endemic countries like India, and for future vac-
cine studies.
http://dx.doi.org/10.1016/j.ijid.2016.02.391
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The role of diabetes in the severity of 2009
inﬂuenza A (H1N1) and the Middle East
respiratory syndrome coronavirus (MERS-CoV):
A systematic review and meta-analysis
A. Badawi1,∗, S. Ryoo2
1 Public Health Agency of Canada, Toronto, Canada
2 University of Toronto, Toronto, Canada
Background: A number of acute respiratory infections out-
breaks such as the 2009 inﬂuenza A (H1N1) and the Middle East
respiratory syndrome coronavirus (MERS-CoV) have emerged and
presented a considerable global public health threat. Epidemio-
logic evidence suggest that diabetic subjects are more susceptible
to these conditions. However, the global inﬂuence of diabetes to
the severity of H1N1 and MERS-CoV is yet to be evaluated.
Objective: The aim of this study was to carry out a systematic
review and meta-analysis documenting the prevalence of diabetes
in sever H1N1 and MERS-CoV to enable estimating its contribution
to the severity of these conditions.
Methods & Materials: A search strategy was developed for
online databases (PubMed, Ovid MEDLINE, Embase and Embase
Classic) using H1N1, MERS-CoV and DIABETES as search terms.
Reportsdocumenting theprevalenceofdiabetes in theseconditions
were identiﬁed. Meta-analysis for the proportions of diabetes in
sever conditions (95% conﬁdence intervals, CI) was carried out (29
H1N1 studies, n=92,948 subjects and 9 MERS-CoV studies, n=308).
Weighted averages of the extracted information and subgroup
analysis (by region) were carried out.
Results: Average age of H1N1 patients (38.0±9.2 yrs) was
lower than that MERS-CoV patients (54.9±10.1 yrs, p<0.05). The
prevalence rates of clinical symptoms such as pyrexia, dyspnea,
pharyngitis and pertussis were comparable between the two con-
ditions. Compared to MERS-CoV patients, H1N1 subjects exhibited
3-fold lower prevalence of cardiovascular diseases and 2- and 4-
foldhigherobesityand immunosuppression rates, respectively. The
prevalenceof diabetes in severH1N1was14.6% (95%CI: 12.3-17.0%;
p<0.001), a 3.7-fold lower than in MERS-CoV (54.4%; 95%CI: 29.4-
79.5; p<0.001). The contribution of diabetes to the severity of H1N1
from Asia (18%) and North America (20%) was 2-fold higher than
that from South America (9.8%) and Europe (10%).
Conclusion: The effect of diabetes is 4-fold higher in MERS-CoV
than in H1N1 and may play a signiﬁcant role in the susceptibly to
these conditions and vulnerability to their ensuing sever compli-
cations. The high prevalence of diabetes in H1N1 in North America
and Asia may reﬂect its elevated prevalence in these regions.
http://dx.doi.org/10.1016/j.ijid.2016.02.392
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Concurrent dengue and malaria coinfection:
Observations from a central Mumbai hospital
A. Barua1,∗, M.E. Yeolekar2
1 k.j somaiya medical college, Mumbai, India
2 K.J.Somaiya Medical College and Hospital, Mumbai,
India
Background: Coinfection by Dengue and Malaria is not uncom-
mon,though studies are scarce. Both remain among the major
causes of acute febrile illnesses in India. The objective of this
study is to understand and observe the interplay of Dengue and
Malaria,compare their clinical and laboratory features and analyze
the outcomes.
Methods & Materials: A comparative, retrospective study of
Dengue, Malaria and their coinfections was carried out, dur-
ing 2 consecutive monsoons (June-November;2014 and 2015),
in a Mumbai hospital. Febrile patients,during this period,were
investigated forbothDengueandMalaria simultaneously. Elisa(NS-
1/IgM) and peripheral smear examination was done to conﬁrm
Dengue and Malaria respectively. Clinical comparison of signs and
symptoms,severity and outcomes, as per predeﬁned criteria was
systematically carried out.. Relevant laboratory parameters were
compared.
Results: During 2014,of 156 included febrile cases,85(54.48%)
were Dengue monoinfection,55(35.25%) isolated Malaria and
16(10.25%) coinfection cases,whereas in 2015, of 417 febrile
cases,272(65.2%)were Dengue,117(28.05%) isolated Malaria and
28(6.7%) were coinfection cases. The coinfection and Dengue
groups presented with a similar clinical picture. Among compared
laboratory parameters,transaminitis was statistically signiﬁcant
in the coinfection group(p<0.001). Anaemia was signiﬁcant in
the Malaria group,whereas,the Dengue group presented with
raised haematocrit and thrombocytopenia. The coinfection group,
with low haemoglobin and haematocrit, was consistent with
concurrent Malaria coinfection. Among compared severity param-
eters,bleeding manifestations,renal dysfunction and jaundice,
was notable in the coinfection group,compared to the Malaria
group(12% & 3.6% and 6.3% & 3.6% each respectively) with 3
mortalities in the Malaria and 1 in the coinfection group dur-
ing 2014. During 2015,despite increased Dengue and coinfection
cases,numerically, with increased jaundice and bleeding manifes-
tations(16% &8% and 8% & 6% respectively),recovery was total.
Conclusion: Dual infection by Dengue and Malaria was
observed by us, for the ﬁrst time, in 2014. This phenomenon,was
noticed to recur, subsequently,during 2015. as well; and there-
fore merits further studies. Awareness and thus routine testing
for both,helps in effective management and reducing mortality as
observed.
http://dx.doi.org/10.1016/j.ijid.2016.02.393
